In this tumor board, the participants will hear a case-based discussion that will include: 

• Surgical and systemic treatment options for oligometastatic disease and factors that influence decision making towards a systemic therapy or surgical option.
• Options for patients who present with regional recurrences despite adjuvant systemic therapy.
• Treatment of in-transit melanoma including intralesional therapies, regional therapies and systemic options.

Moderating this session will be Tina J Hieken, MD, Mayo Clinic

Panelists:

Richard L. White, Jr., MD, FACS, FSSO, Levine Cancer Institute, Atrium Health 
Cristina O'Donoghue, MD, MPH, Rush University
Ryan J. Sullivan, MD, Massachusetts General Hospital
Georgia Beasley, MD, MHSc, Duke University